Kenneth Dipietro has sold CERE and made no open-market buys since Dec 2023
CHRO at Cerevel Therapeutics Holdings, Inc.
SEC CIK 0001540188 · Filings on SEC.gov ↗
$0Bought
$591KSold
NoneLast buy
Every filing
2 filings since Dec 2023, newest first
Filings come from SEC EDGAR. Not investment advice.